Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
11. Juni 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 8014
Artikel 1 - 20 / 160263
Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death-Ligand 1 Expression and F-18-Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Cancer Med
Sun M, Aikedan A, Rui Z, Ding E, Shen J.
PMID: 42267455 [PubMed - in process]
Lung cancer in never-smoking females: epidemiology, risk factors and screening.
Front Public Health
Ding Y, Tao H, Zhu C, Li H, Zhang Y, Du Y, Du L, Gong W, Wang L.
PMID: 42267273 [PubMed - in process]
Radon Exposure as an Occupational Hazard and Environmental Risk Factor for Lung Cancer in Utah: Assessment, Mitigation, and Policy Implications.
J Registry Manag
Daramola O.
PMID: 42267114 [PubMed - in process]
HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8(+) T-cell metabolic suppression.
Front Immunol
Wang J, Wang K, Hu Z, Hu X.
PMID: 42266686 [PubMed - in process]
Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma.
Front Immunol
Lin G, Lin L, Zhao J, Chen G.
PMID: 42266684 [PubMed - in process]
Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.
Ann Surg
Holmes HM, McGann KC, Chen SC, Welch C, Zou Y, Antic S, Forero YJ, Argaw SA, Chen H, Kaizer A, Baron A, Meguid R, Maldonado F, Deppen SA, Grogan EL.
PMID: 42265763 [PubMed - as supplied by publisher]
Multiomics integration prioritizes potential drug targets for lung cancer.
Discov Oncol
Meng P, Zhang Z, Ruan Z, Xu C.
PMID: 42265473 [PubMed - as supplied by publisher]
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocol.
BMJ Open Respir Res
Naidu SB, Guvensen G, Wu H, Omar RZ, Menon U, Popat S, Moore DA, Soo Y, Bhamani A, Thakrar R, Ahmad T, Ppi Group O, Janes SM, Forster MD, Navani N.
PMID: 42264884 [PubMed - in process]
Minimally Invasive/Robotic Surgery for Lung Cancer.
Surg Oncol Clin N Am
Wheelwright M, Su KW, Krantz SB.
PMID: 42264693 [PubMed - in process]
STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY.
Ann Thorac Surg
Tajè R, Gallina FT, Spicer JD.
PMID: 42264017 [PubMed - as supplied by publisher]
TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future Directions.
Pulm Pharmacol Ther
Liu M, Luo R, Liu Y, Fan Y, Zhang J, Liu M.
PMID: 42263842 [PubMed - as supplied by publisher]
Palladium nanoparticles in lung cancer: Emerging strategies for diagnosis and therapeutic intervention.
Pathol Res Pract
Swarn S, Parmar V, Sharma SK, Saini V, Prajapati BG, Alsaidan OA, Alzarea SI, Kapoor DU.
PMID: 42263463 [PubMed - as supplied by publisher]
Differentiating benign from malignant pulmonary nodules in the context of bronchiectasis: a retrospective study.
Ann Med
Wang L, Yang D, Zhou X, Guo T, Liu L, Lei C, Luo H.
PMID: 42262976 [PubMed - indexed for MEDLINE]
Laryngeal leiomyosarcoma: A rare case report and literature review.
Oncotarget
Shalabaev B, Kurash S, Nurzhanov A, Serikbaiuly D, Kochiev B, Manatova A, Burkitbayev Z, Kuanysh Z.
PMID: 42262152 [PubMed - indexed for MEDLINE]
Analyzing the Influence of Surgical Sequence on Perioperative Circulating Tumor Cells in Patients with Resectable Non-Small Cell Lung Cancer.
Cancer Manag Res
Chen H, He Y, Wang Y, Liu X, Zou G.
PMID: 42261330 [PubMed]
LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies.
Cancer Inform
Hu W, Wu G, Lin Y, Li S, Lin Z, Chen Y, Cheng Z, Zeng J, Yang Z, Wang Y.
PMID: 42261303 [PubMed]
Prognostic role of the systemic immune-inflammation in patients with non-small cell lung cancer: A meta-analysis.
J Pak Med Assoc
Zhao G, Zhang H, Ye P, Chen W.
PMID: 42261026 [PubMed - in process]
miR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways.
Medicine (Baltimore)
Li W, Xia B, Deng S.
PMID: 42260863 [PubMed - in process]
Integrated transcriptomics, network pharmacology and clinical expression validation reveal the prognostic significance of PANoptosis-related genes in cordycepin-treated lung adenocarcinoma.
Discov Oncol
Xu H, Huang W, Yang Q, Chen Y, Su P, Fu B.
PMID: 42260221 [PubMed - as supplied by publisher]
Addressing Data Quality Challenges in Lung Cancer Data Within the Observational Medical Outcomes Partnership Common Data Model: Observational Study.
J Med Internet Res
Declerck J, Deschepper M, Colpaert K, Kalra D, Coorevits P.
PMID: 42258805 [PubMed - in process]
Artikel 1 - 20 / 160263
Seite 1 von 8014
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung